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CASE REPORT

Cardiac Sarcoma Presenting as Tamponade
Mosunmoluwa Oyenuga a,*, Sandeep Sen b, Rushin Patel a, Shahin Ali a,
Sara Sartaj a, Alexandre Lacasse a
a
b

Department of Internal Medicine, SSM St. Mary's Hospital, St. Louis, MO, USA
Division of Hematology/Oncology, SSM St. Mary's Hospital, St. Louis, MO, USA

Abstract
Sarcomas are a broad group of neoplasm that originate from the mesenchymal layer and represent about 1% of malignancy in the adult population. We describe a 46-year-old woman with no prior medical history who presented with
worsening dyspnea. Physical examination was signiﬁcant for jugular venous distension and bilateral lower extremity
edema. Chest Xray showed cardiomegaly. Echocardiography showed a normal ejection fraction of 65%, pericardial
effusion with tamponade physiology and three epicardial masses. Patient had pericardiocentesis performed followed by
pericardial window. Biopsy of pericardial mass showed morphologic and immunophenotypic ﬁndings supportive of
diagnosis of malignant soft tissue sarcoma. Though this type of cancer is rare, malignancy should be included as one of
the differential diagnoses of new-onset pericardial effusion in a young patient. Early diagnosis and referral to a
specialized sarcoma center for treatment is recommended.
Keywords: Cardiac sarcoma, Sarcoma, Small round blue cell tumor, Cardiac tamponade, Pericardial effusion, Cardiomegaly, Leg swelling

1. Introduction

S

arcomas are a broad group of neoplasms that
originate from the mesenchymal layer. They
represent about 20% of malignancies seen in the
pediatric population compared to 1% in the adult
one.1 Common locations include the bone, muscles, cartilage, joints, and nerves. Sarcomas arising
from the heart are rare and have been associated
with poor prognosis. Primary cardiac tumors have
been reported in approximately 0.001e0.3% of
autopsies.2 About 90% are benign and 10% are
malignant.3 Of the malignant tumors, about 75%
are sarcomas.2 Primary cardiac malignant tumors
usually occur in young patients with a median age
of 44 years, and it is equally distributed between
genders.4 Based on histology, the most common
types of cardiac sarcomas are angiosarcomas, undifferentiated sarcomas, and undifferentiated
pleomorphic sarcomas.5 These malignant tumors
are rapidly progressive and produce early death

through inﬁltration of the myocardium, obstruction of circulation, or distant metastases to lungs,
lymph nodes, and liver. We present a 46-year-old
female who presented with progressive dyspnea
and leg edema. Cardiac tamponade was present
and managed accordingly. Cardiac sarcoma was
later diagnosed based on further imaging and
biopsy. The patient was then transferred to a
specialized
sarcoma
center
for
further
management.

2. Case
A 46-year-old woman with no prior medical history apart from recent diagnosis for hypertension
presented to the emergency department on account
of progressive dyspnea on exertion for three months
and bilateral leg edema. Signiﬁcant physical examination ﬁndings included elevated jugular venous
distension (JVD) and bilateral lower extremity
edema. Laboratory ﬁndings showed normal brain
natriuretic peptide (BNP) 15 pg/ml (normal range-
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<100 pg/ml), elevated alanine aminotransferase
(ALT) - 180 U/L (normal range- 0e61 U/L), aspartate
aminotransferase (AST) - 110 U/L (normal range 5e34 U/L), normal thyroid stimulating hormone
(TSH) - 3.1 uIU/ml (normal range- 0.35 - 4.94 uIU/
ml). Acute hepatitis serologies were negative, HIV
serologies/P24 antigen ELISA, and autoimmune
markers including antinuclear antibodies (ANA)
and rheumatoid factor (RF) were negative. Chest
Xray (CXR) showed marked cardiomegaly suspicious for pericardial effusion (Fig. 1). Computed
tomography (CT) scan of the chest, abdomen, and
pelvis were remarkable for large pericardial effusion, trace ascites, and incidental ﬁnding of a 5.3 cm
hepatic cyst. Transthoracic echocardiography (TTE)
showed normal left ventricular function (ejection
fraction e 65%) and large echo-free pericardial
effusion up to 4 cm with associated right ventricular
and right atrial diastolic collapse suggestive of
tamponade physiology. The inferior vena cava was
dilated with minimal respiratory variation. Additionally, 3 round masses were identiﬁed (largest
5.3  3 cm) and were attached to the epicardium
within the pericardial base (Fig. 2). Pericardiocentesis was performed under ﬂuoroscopy guidance
which resulted in drainage of 1500 ml of bloody
ﬂuid and pericardial drain placement. Fluid analysis
showed nucleated cell count of 357  10E6/L and
red blood cell (RBC) 161,000  10E6/L. Cytology as
well as routine culture, fungal, viral, acid-fast bacilli,
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and anaerobic culture were negative. Flow cytometry of the pericardial ﬂuid showed no evidence of
non-Hodgkin's lymphoma or high-grade myeloma
neoplasm. Following removal of the drain, re-accumulation of ﬂuid was seen on repeat TTE within
24 h. Mini thoracotomy with pericardial window
and biopsy of a large encapsulated epicardial mass
with necrotic center at the Right Atrium/Left Atrium
groove were performed. Intraoperative ﬁndings
showed large mass attached to the epicardium at the
interatrial groove adherent to the right superior
pulmonary vein, right atrial wall, and left atrial wall.
Intraoperative frozen section was consistent with
malignancy - small blue cell tumor, no gross tumor
seeding, or evidence of tumor nodules in the lung or
pleura. Biopsy showed morphologic and immunophenotypic ﬁndings supporting a diagnosis of a
malignant small round blue cell tumor including
monophasic synovial sarcoma, desmoplastic small
round cell tumor, or Ewing sarcoma. Numerous
stains including neuroendocrine, vascular, muscle,
lymphoid, and other epithelial markers were negative. Flow cytometric analysis performed by Integrated Oncology (AFT21-011,370) showed 3% of
total events to have scatter characteristics of lymphocytes, 89% of which were CD3-positive T-cells.
The T-cells had a CD4-to-CD8 ratio of 0.6 and
demonstrated retained expression of CD2, CD5, and
CD7. There were insufﬁcient B-cells for clonality
studies. Fluorescence in situ hybridization (FISH)

Fig. 1. Chest Xray showing markedly enlarged heart.
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Fig. 2. Echocardiography ﬁnding showing epicardial mass.

studies were negative for SS18 (SYT) (18q11) gene
arrangement and EWSR1 (22q12) gene arrangement. Patient was then transferred to a sarcoma
center for further management where chemotherapy was initiated. One year later, patient has
completed two rounds of chemotherapy and now on
immunotherapy. Restaging scans with cardiac
magnetic resonance imaging (MRI) showed slightly
decreased cardiac masses and CT imaging were
negative for distant metastases.

3. Discussion
Cardiac sarcomas though rare can be aggressive.
Therefore, early diagnosis and treatment is important for overall survival. Patients usually present
with similar symptoms suggestive of an underlying
heart disease. The common manifestations that have
been reported include dyspnea (48%), chest pain
(22%), heart failure (13%), and pericarditis (5%).6
Initial workup for common causes of dyspnea
includes a CXR which in our patient showed a
globular heart concerning for pericardial effusion,
then conﬁrmed by TTE. Pericardial effusion and
cardiac tamponade are common ﬁndings that have
been previously reported in patients diagnosed with
cardiac sarcoma.7,8 TTE is the ﬁrst diagnostic imaging to evaluate the size, site of origin, mobility,
and hemodynamic effects of the tumor.3 In patients
with cardiac tamponade, the initial procedure of
choice is pericardiocentesis. In patients with recurrent effusion, a surgical pericardial window is

usually needed.9 A contrast TTE can also be useful
to differentiate vascular tumors from thrombi. Most
malignant tumors are heavily vascularized and
show signiﬁcant contrast enhancement while
benign tumors i.e., myxomas show less contrast
enhancement. Thrombi show complete absence of
contrast opaciﬁcation being avascular structures.10
CT can provide useful information on site of origin,
anatomical relationships, surrounding structures
involvement and extracardiac localization.11
Cardiac MRI remains the best available noninvasive diagnostic tool to provide information about
morphology, dimensions, location, extension,
perfusion, and tissue characterization of the mass.11
Positron Emission Tomography (PET) scan using
18F-ﬂuoro-D-glucose (FDG) in combination with CT
(or MRI) can also be used to assess cardiac masses,
differentiating benign and malignant tumors by the
extent of FDG uptake by tumors.12 Further CT
abdomen and pelvis is recommended given the high
likelihood of extra-peritoneal metastasis to the
abdomen and retroperitoneum especially in round
cell/myxoid liposarcomas.
Management of patients with cardiac sarcomas
may vary according to the stage at diagnosis. Primary cardiac sarcomas are best classiﬁed by the site
of origin. which is further directly linked to the
surgical approach used for resection.13 In early
stage, surgical removal is suitable although feasible
in only in less than half of patients as most have
evidence of metastasis at the time of presentation or
most tumors recur rapidly, limiting survival to

approximately one year.14,15 Cytoreductive chemotherapy with or without radiotherapy are other
therapeutic options.16 First line chemotherapy
would include Adriamycin, whereas second line
gemcitabine plus docetaxel would be used. Nevertheless, the impact of chemotherapies on the natural
history of cardiac sarcomas is limited, and hence the
importance of a multidisciplinary evaluation to
deﬁne the best therapeutic approach based on the
experience of the group.13
In conclusion, primary cardiac neoplasms should
be included in the differential diagnosis of new
onset pericardial effusion in a younger patient.
Though the prognosis of primary cardiac sarcoma is
poor, early diagnosis, surgical resection, and
chemotherapy may prolong survival.
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